Axillary Hyperhidrosis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2024-12-24
Clinical Trial Update: Assessment of Safety, Tolerability and Efficacy of 1% GPB Cream Versus Qbrexza® (Glycopyrronium) Cloth 2.4% Under Maximum-Use Conditions in Subjects with Primary Axillary Hyperhidrosis [Phase 2]
Phase 2 trial comparing 1% GPB Cream with Qbrexza glycopyrronium cloth for Primary Axillary Hyperhidrosis has been withdrawn.